We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
Genetics research has made momentous strides in the 21st century. At the start of the century, we had a broad understanding that most medical problems in the developed world are partly genetically determined but lacked the technology to fully explore the secrets hiding in our genome.
By NIHR Maudsley BRC at 26 Jan 2022
Dr Daniel Martins is a Clinical Research Associate, Dr Mattia Veronese is a senior molecular imaging scientist and Dr. Ottavia Dipasquale is a Research Associate, all in the Department of Neuroimaging at King’s College London. In this blog they discuss their recent study which is funded by the NIHR Maudsley BRC and has brought together scientists from across the world to define a new approach to integrate neuroimaging and a form of genetic mapping.
By NIHR Maudsley BRC at 21 Jan 2022A clinical trial that is collecting data on the features of opioid overdoses within the safety of a clinical setting will be integrating a monitoring platform into the research to investigate how to prevent deaths from breathing problems in opioid users.
By NIHR Maudsley BRC at 20 Jan 2022Naghmeh Nikkheslat is a Senior Research Associate at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) who is working on a project funded by the NIHR Maudsley BRC to investigate the use of ketamine as a medication for depression. In this blog, she talks about her research into depression and the immune system and what we currently know about ketamine as an anti-inflammatory antidepressant in psychiatric emergencies.
By NIHR Maudsley BRC at 10 Jan 2022Researchers from King’s College London and South London and Maudsley NHS Foundation Trust have shown that there are variations in how a brain chemical called GABA regulates the processing of visual stimuli. The study showed that when autistic people are given a drug that activates GABA targets, their visual processing becomes more like that of non-autistic people.
By NIHR Maudsley BRC at 6 Jan 2022
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2024 | Website design by CSMB Design | All rights reserved.
